☰

Sara N Musetti - Publications

Affiliations: 
2021 Eshelman School of Pharmacy University of North Carolina, Chapel Hill, Chapel Hill, NC 
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Musetti SN, Huang L. Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer. Molecular Pharmaceutics. 18: 2032-2038. PMID 33877834 DOI: 10.1021/acs.molpharmaceut.1c00008  0.529
2020 Zhu H, Liu Q, Miao L, Musetti S, Huo M, Huang L. Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy. Nanoscale. PMID 31989142 DOI: 10.1039/C9Nr09610H  0.589
2020 Musetti S, Leaf H. Tinagl1 gene therapy for tumor-wide remodeling of triple negative breast cancer European Journal of Cancer. 138: S37-S38. DOI: 10.1016/s0959-8049(20)31172-2  0.364
2020 Xiong Y, Song W, Shen L, Wang Y, Zhang J, Hu M, Liu Y, Li J, Musetti S, Liu R, Huang L. Oral Metformin and Polymetformin Reprogram Immunosuppressive Microenvironment and Boost Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Advanced Therapeutics. 3: 2000168. DOI: 10.1002/adtp.202000168  0.546
2019 Qi C, Musetti S, Fu LH, Zhu YJ, Huang L. Biomolecule-assisted green synthesis of nanostructured calcium phosphates and their biomedical applications. Chemical Society Reviews. PMID 31080987 DOI: 10.1039/c8cs00489g  0.339
2018 Das M, Musetti S, Huang L. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise. Nucleic Acid Therapeutics. PMID 30562145 DOI: 10.1089/nat.2018.0762  0.429
2018 Musetti S, Huang L. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy. Acs Nano. PMID 30508378 DOI: 10.1021/acsnano.8b05893  0.521
2017 Liu L, Wang Y, Miao L, Liu Q, Musetti S, Li J, Huang L. Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29258739 DOI: 10.1016/j.ymthe.2017.10.020  0.485
2017 Liu Q, Zhu H, Liu Y, Musetti S, Huang L. BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunology, Immunotherapy : Cii. PMID 29094184 DOI: 10.1007/s00262-017-2079-7  0.483
2017 Song W, Musetti SN, Huang L. Nanomaterials for cancer immunotherapy. Biomaterials. 148: 16-30. PMID 28961532 DOI: 10.1016/j.biomaterials.2017.09.017  0.554
2017 Shi K, Zhao Y, Miao L, Satterlee A, Haynes M, Luo C, Musetti S, Huang L. Dual Functional LipoMET Mediates Envelope-type Nanoparticles to Combinational Oncogene Silencing and Tumor Growth Inhibition. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28274796 DOI: 10.1016/j.ymthe.2017.02.008  0.459
2016 Goodwin TJ, Zhou Y, Musetti SN, Liu R, Huang L. Local and transient gene expression primes the liver to resist cancer metastasis. Science Translational Medicine. 8: 364ra153. PMID 27831902 DOI: 10.1126/scitranslmed.aag2306  0.447
2016 Luo C, Sun J, Liu D, Sun B, Miao L, Musetti S, Li J, Han X, Du Y, Li L, Huang L, He Z. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy. Nano Letters. PMID 27490088 DOI: 10.1021/acs.nanolett.6b01632  0.401
2016 Luo C, Miao L, Zhao Y, Musetti S, Wang Y, Shi K, Huang L. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. Biomaterials. 102: 239-248. PMID 27344367 DOI: 10.1016/j.biomaterials.2016.06.030  0.467
Show low-probability matches.